Skip to Main Content

Paper Details

Delta-24 adenoviral therapy for glioblastoma: evolution from the bench to bedside and future considerations.
Neurosurg Focus
14
2021
Author NameAffiliation
Juan Fueyo
Juan FueyoThe University of Texas MD Anderson Cancer Center
Frederick F Lang
  • 1 - 3

Datasets

Release 1.2